Genomic aberrations in early stage human hepatocellular carcinomas
Hisaki Nagai(Nippon Medical School), Kenichi Matsubara(Nara Institute of Science and Technology), Jiro Fujimoto(Harvard University), Hidenao Yamamoto(Hyogo Medical University), Noboru Konishi(Nara Medical University), Yong‐Sung Kim(Korea Research Institute of Standards and Science), Mathurose Ponglikitmongkol(Mahidol University)
Cited by 11
Related Papers
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
|Nature Genetics|2001|734
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
|International Immunology|2008|480
Regulation of the Estrogen Receptor in MCF-7 Cells by Estradiol
|Molecular Endocrinology|1988|339